Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The importance of immunization in cancer prevention, treatment, and survivorship
Elizabeth Ward, Christopher R. Flowers, Ted Gansler, et al.
CA A Cancer Journal for Clinicians (2017) Vol. 67, Iss. 5, pp. 398-410
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Immune-related adverse events of checkpoint inhibitors
Manuel Ramos‐Casals, Julie R. Brahmer, Margaret K. Callahan, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 1020
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu, Minyang Fu, Manni Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 481
Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development
Weihua Yu, Yongmei Tu, Zi Long, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 76
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy
Popat Mohite, Vaishnavi Yadav, Ramdas Pandhare, et al.
ACS Omega (2024)
Open Access | Times Cited: 19
SARS-CoV-2 vaccines for cancer patients: a call to action
Chiara Corti, Edoardo Crimini, Paolo Tarantino, et al.
European Journal of Cancer (2021) Vol. 148, pp. 316-327
Open Access | Times Cited: 63
Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Autophagy-targeted nanoparticles for effective cancer treatment: advances and outlook
Xuehua Long, Jianqin Yan, Zhuoran Zhang, et al.
NPG Asia Materials (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 34
S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer
Yuan Chen, Chengcheng Wang, Jianlu Song, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
Removing the sporoderm from the sporoderm-broken spores of Ganoderma lucidum improves the anticancer and immune-regulatory activity of the water-soluble polysaccharide
Liu Fang, Qian Zhao, Cuiling Guo, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 20
Gastric Cancer Survivorship: Multidisciplinary Management, Best Practices and Opportunities
Era Cobani, Mohammed Najeeb Al Hallak, Anthony F. Shields, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 55, Iss. 2, pp. 519-533
Closed Access | Times Cited: 4
The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors
Ana Carolina Ramos Moreno, Bruna F.M.M. Porchia, Roberta Liberato Pagni, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 37
Genetic and phenotypic difference in CD8+ T cell exhaustion between chronic hepatitis B infection and hepatocellular carcinoma
Xiaochen Wang, Qifeng He, Haiyuan Shen, et al.
Journal of Medical Genetics (2018) Vol. 56, Iss. 1, pp. 18-21
Open Access | Times Cited: 29
Single-Cell Sequencing Identifies the Heterogeneity of CD8+ T Cells and Novel Biomarker Genes in Hepatocellular Carcinoma
Hailei Wang, Yang‐Xin Fu, Bin-Bin Da, et al.
Journal of Healthcare Engineering (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 14
Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach
Falak Goyal, Anandini Chattopadhyay, Umashanker Navik, et al.
Advanced Therapeutics (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 8
Rapid expansion in the WAVE bioreactor of clinical scale cells for tumor immunotherapy
Yiming Meng, Jing Sun, Tingting Hu, et al.
Human Vaccines & Immunotherapeutics (2018) Vol. 14, Iss. 10, pp. 2516-2526
Open Access | Times Cited: 21
Uptake Characterization of Tumor Cell-derived Exosomes by Natural Killer Cells.
Ting Huyan, Yongyong Du, Qiuping Huang, et al.
PubMed (2018) Vol. 47, Iss. 6, pp. 803-813
Closed Access | Times Cited: 21
The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma
Yongying Zhou, Xiao Wang, Weibing Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
Novel Prognostic Biomarkers in Gastric Cancer: CGB5, MKNK2, and PAPPA2
Min Qin, Zhihai Liang, Heping Qin, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13
IL-17 signaling pathway plays a key role in laryngeal squamous cell carcinoma with ethnic specificity
Qi Li, Wenzhao Bao, Wei Li, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 6, pp. 2684-2695
Closed Access | Times Cited: 12
Influenza Vaccination Rates Among Patients With a History of Cancer: Analysis of the National Health Interview Survey
Andrés Chang, Mallory K. Ellingson, Christopher R. Flowers, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 11
Current Strategies for Targeting Autophagy and ROS for Cancer Treatment
Raghuraj Singh, Krishna Jadhav, Nandan Rawat, et al.
Cancer drug discovery and develogment/Cancer drug discovery and development (2024), pp. 287-307
Closed Access | Times Cited: 1
Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and “First Do No Harm” Part II
Mark A. Moyad
Current Urology Reports (2020) Vol. 21, Iss. 3
Closed Access | Times Cited: 7
Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell Lymphoma
Andrés Chang, Jackelyn B. Payne, Pamela B. Allen, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 4, pp. 239-243
Open Access | Times Cited: 5
COVID-19 Vaccines: Preparing for Vaccination in the Context of Clinical Oncology Care
Ellen Carr
Clinical journal of oncology nursing (2021) Vol. 25, Iss. 1, pp. 76-84
Closed Access | Times Cited: 5
What gastroenterologists should know about SARS–CoV 2 vaccine: World Endoscopy Organization perspective
Marco Spadaccini, Lorenzo Maria Canziani, Alessio Aghemo, et al.
United European Gastroenterology Journal (2021) Vol. 9, Iss. 7, pp. 787-796
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top